squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Dose Escalation Using Hypoxia-adjusted Radiotherapy#851808ClinicalTrials.gov
• A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC#898451ClinicalTrials.gov
• A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases#834778ClinicalTrials.gov
• A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours#828271ClinicalTrials.gov
• Quantifying Systemic Immunosuppression to Personalize Cancer Therapy#851374ClinicalTrials.gov
• Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer#804902ClinicalTrials.gov
• SpectroLive : optical spectra (autofluorescence and diffuse reflectance) acquired on human skin carcinomas#499397Recherche Data Gouv Dataverse OAI Archive
• Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer#899203ClinicalTrials.gov
• Spatial subsetting enables integrative modeling of oral squamous cell carcinoma multiplex imaging data#453433Scholarly Commons
• Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.#249611ClinicalTrials.gov
• Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss#865627ClinicalTrials.gov
• Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)#882612ClinicalTrials.gov
• Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy#303573ClinicalTrials.gov
• Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy#435776ClinicalTrials.gov
• Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer#885648ClinicalTrials.gov
• Cirugía de Mohs : desenlaces y asociación entre el tipo de tumor, su tamaño y la infiltración perineural y el número de etapas requeridas. Estudio de cohorte retrospectiva.#431622Repositorio Institucional Javeriano
• Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus#855247ClinicalTrials.gov
• Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma#857138ClinicalTrials.gov
• A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States#858280ClinicalTrials.gov
• Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)#874410ClinicalTrials.gov
• A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)#842721ClinicalTrials.gov
• Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing#226900HAL (France)
• Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo#851447ClinicalTrials.gov
• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study#411390ClinicalTrials.gov
• [Formula: see text] 2 [Formula: see text] 1 may be a potential marker for cancer stem cell in laryngeal squamous cell carcinoma#129225PMC Full-Text (OAI)
• Programmed cell death ligand 1(PD-L1) association in metastatic and non-metastatic oral squamous cell carcinoma: clinicopathologic and immunohistochemical study.#345193NCBI PubMed Central
• The role of the tumor microenvironment in drug resistance acquisition in lung squamous cell carcinoma.#750NCBI PubMed Central
• Application of artificial intelligence in head and neck squamous cell carcinoma#4697Europe PMC
• Patient-Centred Web-Based Information on Head and Neck Squamous Cell Carcinoma: Quality and Readability.#13751NCBI PubMed Central
• WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma.#125462NCBI PubMed Central
• Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)#143546ClinicalTrials.gov
• Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence#146282ClinicalTrials.gov
• The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer#146444ClinicalTrials.gov
• Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC#208467ClinicalTrials.gov
• Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma#217028ClinicalTrials.gov
• Effect of Oral Peritumoral Tissue on Infiltration and Differentiation of Tumor-Associated Macrophages in Oral Squamous Cell Carcinoma#251457OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer#256834ClinicalTrials.gov
• Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN#261492ClinicalTrials.gov
• Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC#332753ClinicalTrials.gov
• Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC#366613ClinicalTrials.gov
• Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China#460078ClinicalTrials.gov
• Cancer-associated fibroblasts and immune remodeling in laryngeal squamous cell carcinoma: evidence and translational perspectives.#653443NCBI PubMed Central
• HN-QUEST: A Study of Head and Neck Imaging Biomarkers#843121ClinicalTrials.gov
• Multicentric Retrospective Review of Extracapsular Lymph Node Involvement After Esophagectomy#863774ClinicalTrials.gov
• Pre-Surgery If Needed for Oesophageal Cancer#865817ClinicalTrials.gov
• Efficacy Study of Temsirolimus to Treat Head and Neck Cancer#875140ClinicalTrials.gov
• A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung#18581ClinicalTrials.gov
• A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors#804465ClinicalTrials.gov
• Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma#852526ClinicalTrials.gov
• Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck Carcinoma#828171ClinicalTrials.gov